期刊中文名:罕見腫瘤ISSN:2036-3605E-ISSN:2036-3613
該雜志國際簡稱:RARE TUMORS,是由出版商SAGE Publishing出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術(shù)影響力。
《Rare Tumors》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱罕見腫瘤,本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為0.9,最新CiteScore 指數(shù)為1.5。
Rare Tumors is an academic journal published by PAGEPress, focusing on the research and reporting of rare tumors. This journal provides a platform for medical and oncology researchers to publish and share rare cancer cases and research findings. Due to the limited number of cases of rare tumors, related research often struggles to receive sufficient attention. Therefore, journals play an important role in promoting knowledge dissemination and research collaboration in this field.
Journal content typically includes original research papers, case reports, review articles, technical reports, and reviews, covering a wide range of topics such as epidemiology of rare tumors, molecular biology, diagnostic techniques, treatment strategies, clinical trial results, and patient care and management. These contents not only focus on basic research, but also emphasize clinical applications, providing readers with opportunities to understand rare tumors from multiple perspectives. The editorial team of the magazine is composed of renowned scholars and experts in the field, who are responsible for the editorial work of the journal, including article collection, peer review, and final publication. The journal adopts a strict peer review process to ensure that the published articles have high quality and academic value.
按JIF指標學科分區(qū) |
學科:ONCOLOGY
收錄子集:ESCI
分區(qū):Q4
排名:293 / 322
百分位:
9.2% |
按JCI指標學科分區(qū) |
學科:ONCOLOGY
收錄子集:ESCI
分區(qū):Q4
排名:290 / 322
百分位:
10.09% |
JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學科。JCR分區(qū)根據(jù)每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。
學科類別 | 分區(qū) | 排名 | 百分位 |
大類:Medicine 小類:Oncology | Q3 | 289 / 404 |
28% |
大類:Medicine 小類:Histology | Q4 | 49 / 62 |
21% |
該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認可很高,對稿件內(nèi)容的創(chuàng)新性和學術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 15 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。
若用戶需要出版服務(wù),請聯(lián)系出版商。